Second Sight Medical Products, Inc. announced that the Company received notice from the National Institutes of Health of the release of year four funding for its Early Feasibility Clinical Trial of a Visual Cortical Prosthesis (the “Orion Trial”), grant 5UH3NS103442. The NIH released $1.1 million of the $6.4 million planned five-year grant. The Company uses the funds primarily to pay UCLA and Baylor College of Medicine to conduct the Orion Trial.

The funding supports continuation of this important research and testing of the Orion Visual Cortical Prosthesis.